Activation of mitogen-activated protein kinases cellular signal transduction pathway in mammalian cells induced by silicon carbide nanowires

Biomaterials

Volumn 31, Issue 31, 2010, Pages 7856-7862

  Jiang, Jiang ^a,b   Wang, Jun ^b   Zhang, Xuming ^c   Huo, Kaifu ^a,c   Wong, Hoi Man ^d   Yeung, Kelvin W K ^d   Zhang, Wenjun ^a   Hu, Tao ^a   Chu, Paul K ^a  

^a CITY UNIVERSITY OF HONG KONG   (Hong Kong)

^b INSTITUTE OF PLASMA PHYSICS   (China)

^c WUHAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Apoptosis; Cyclooxygenase 2; Genomic instability; Mitogen activated protein kinases; Phosphorylation; Silicon carbide nanowires

Indexed keywords

BACTERIOPHAGES; CELL DEATH; CHEMICAL ACTIVATION; ENZYME ACTIVITY; GENES; MAMMALS; MEDICAL APPLICATIONS; NANOWIRES; PHOSPHORYLATION; SILICON CARBIDE; TOXICITY;

CELLULAR SIGNAL TRANSDUCTION; CHINESE HAMSTER OVARY CELLS; CYCLOOXYGENASE 2; GENOMIC INSTABILITY; MITOGEN ACTIVATED PROTEIN KINASE; P38 MITOGEN-ACTIVATED PROTEIN KINASE; SIGNAL-REGULATED KINASE; SILICON CARBIDE NANOWIRES;

SIGNAL TRANSDUCTION;

CYCLOOXYGENASE 2; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NANOWIRE; SILICON CARBIDE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CHINESE HAMSTER; CHO CELL; CONTROLLED STUDY; FEMALE; GENOMIC INSTABILITY; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REPRODUCTION; SIGNAL TRANSDUCTION;

CRICETULUS GRISEUS; MAMMALIA;

EID: 77956010368     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.07.024     Document Type: Article

References (61)

1. Vasir J.K., Labhasetwar V. Quantification of the force of nanoparticle-cell membrane interactions and its influence on intracellular trafficking of nanoparticles. Biomaterials 2008, 29(31):4244-4252.
2. Botsoa J., Lysenko V., Geloen A., Marty O., Bluet J.M., Guillot G. Application of 3C-SiC quantum dots for living cell imaging. Appl Phys Lett 2008, 92(17):173902-173903.
3. Tong R., Christian D.A., Tang L., Cabral H., Baker J.R., Kataoka K., et al. Nanopolymeric therapeutics. MRS Bull 2009, 34(6):422-431.
4. Duncan R. Polymer conjugates as anticancer nanomedicines. Nat Rev Cancer 2006, 6(9):688-701.
5. Gonzalez P., Serra J., Liste S., Chiussi S., Leon B., Perez-Amor M., et al. New biomorphic SiC ceramics coated with bioactive glass for biomedical applications. Biomaterials 2003, 24(26):4827-4832.
6. Shi W.S., Zheng Y.F., Peng H.Y., Wang N., Lee C.S., Lee S.T. Laser ablation synthesis and optical characterization of silicon carbide nanowires. J Am Ceram Soc 2000, 83(12):3228-3230.
7. Tong L.R., Reddy R.G. Thermal plasma synthesis of SiC nano-powders/nano-fibers. Mater Res Bull 2006, 41(12):2303-2310.
8. Wong E.W., Sheehan P.E., Lieber C.M. Nanobeam mechanics: Elasticity, strength, and toughness of nanorods and nanotubes. Science 1997, 277(5334):1971-1975.
9. Zhou W.M., Liu X., Zhang Y.F. Simple approach to beta-SiC nanowires: synthesis, optical, and electrical properties. Appl Phys Lett 2006, 89(22):223124-223133.
10. Pan Z.W., Lai H.L., Au F.C.K., Duan X.F., Zhou W.Y., Shi W.S., et al. Oriented silicon carbide nanowires: synthesis and field emission properties. Adv Mater 2000, 12(16):1186-1190.
11. Wong K.W., Zhou X.T., Au F.C.K., Lai H.L., Lee C.S., Lee S.T. Field-emission characteristics of SiC nanowires prepared by chemical-vapor deposition. Appl Phys Lett 1999, 75(19):2918-2920.
12. Ho G.W., Wong A.S.W., Kang D.J., Welland M.E. Three-dimensional crystalline SiC nanowire flowers. Nanotechnology 2004, 15(8):996-999.
13. Fan J.Y., Li H.X., Jiang J., So L.K.Y., Lam Y.W., Chu P.K. 3C-SiC nanocrystals as fluorescent biological labels. Small 2008, 4(8):1058-1062.
14. Wu X.L., Xiong S.J., Zhu J., Wang J., Shen J.C., Chu P.K. Identification of surface structures on 3C-SiC nanocrystals with hydrogen and hydroxyl bonding by photoluminescence. Nano Lett 2009, 9(12):4053-4060.
15. Locs J., Berzina-Cimdina L., Zhurinsh A., Loca D. Optimized vacuum/pressure sol impregnation processing of wood for the synthesis of porous, biomorphic SiC ceramics. J Eur Ceram Soc 2009, 29(8):1513-1519.
16. Reece J., Campbell N.A. Biology 2002, Pearson Education International, San Francisco.
17. Zhou H., Ivanov V.N., Gillespie J., Geard C.R., Amundson S.A., Brenner D.J., et al. Mechanism of radiation-induced bystander effect: role of the cyclooxygenase-2 signaling pathway. Proc Natl Acad Sci USA 2005, 102(41):14641-14646.
18. Zhou H.N., Ivanov V.N., Lien Y.C., Davidson M., Hei T.K. Mitochondrial function and nuclear factor-kappa B-mediated signaling in radiation-induced bystander effects. Cancer Res 2008, 68(7):2233-2240.
19. Chang M.C., Lin L.D., Chan C.P., Chang H.H., Chen L.I., Lin H.J., et al. The effect of BisGMA on cyclooxygenase-2 expression, PGE(2) production and cytotoxicity via reactive oxygen species- and MEK/ERK-dependent and -independent pathways. Biomaterials 2009, 30(25):4070-4077.
20. Huang F.M., Chang Y.C. Prevention of the epoxy resin-based root canal sealers-induced cyclooxygenase-2 expression and cytotoxicity of human osteoblastic cells by various antioxidants. Biomaterials 2005, 26(14):1849-1855.
21. Im G.I., Kwon B.C., Lee K.B. The effect of COX-2 inhibitors on periprosthetic osteolysis. Biomaterials 2004, 25(2):269-275.
22. Fenech M., Morley A.A. Cytokinesis-block micronucleus method in human-lymphocytes - effect of in vivo aging and low-dose X-irradiation. Mutat Res 1986, 161(2):193-198.
23. Albertini R.J., Anderson D., Douglas G.R., Hagmar L., Hemminki K., Merlo F., et al. IPCS guidelines for the monitoring of genotoxic effects of carcinogens in humans. Mutat Res 2000, 463(2):111-172.
24. Heinrich P.C., Behrmann I., Haan S., Hermanns H.M., Muller-Newen G., Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 2003, 374(Pt 1):1-20.
25. Zhang Y., Feng X.H., Derynck R. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription. Nature 1998, 394(6696):909-913.
26. Deak M., Clifton A.D., Lucocq L.M., Alessi D.R. Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB. Embo J 1998, 17(15):4426-4441.
27. Uhlik M.T., Abell A.N., Johnson N.L., Sun W., Cuevas B.D., Lobel-Rice K.E., et al. Rac-MEKK3-MKK3 scaffolding for p38 MAPK activation during hyperosmotic shock. Nat Cell Biol 2003, 5(12):1104-1110.
28. Du Y., Ma Z., Lin S., Dodel R.C., Gao F., Bales K.R., et al. Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. Proc Natl Acad Sci USA 2001, 98(25):14669-14674.
29. Seger R., Krebs E.G. Protein kinases 7. The MAPK signaling cascade. FASEB J 1995, 9(9):726-735.
30. Tibbles L.A., Woodgett J.R. The stress-activated protein kinase pathways. Cell Mol Life Sci 1999, 55(10):1230-1254.
31. Widmann C., Gibson S., Jarpe M.B., Johnson G.L. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev 1999, 79(1):143-180.
32. Davis R.J. Signal transduction by the JNK group of MAP kinases. Cell 2000, 103(2):239-252.
33. Chang L., Karin M. Mammalian MAP kinase signalling cascades. Nature 2001, 410(6824):37-40.
34. Johnson G.L., Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002, 298(5600):1911-1912.
35. Dent P., Yacoub A., Fisher P.B., Hagan M.P., Grant S. MAPK pathways in radiation responses. Oncogene 2003, 22(37):5885-5896.
36. Karoubi G., Ormiston M.L., Stewart D.J., Courtman D.W. Single-cell hydrogel encapsulation for enhanced survival of human marrow stromal cells. Biomaterials 2009, 30(29):5445-5455.
37. Cushing M.C., Liao J.T., Jaeggli M.P., Anseth K.S. Material-based regulation of the myofibroblast phenotype. Biomaterials 2007, 28(23):3378-3387.
38. Lavoie J.N., LAllemain G., Brunet A., Muller R., Pouyssegur J. Cyclin D1 expression is regulated positively by the p42/p44(MAPK) and negatively by the p38/HOG(MAPK) pathway. J Biol Chem 1996, 271(34):20608-20616.
39. Irani K., Xia Y., Zweier J.L., Sollott S.J., Der C.J., Fearon E.R., et al. Mitogenic signaling mediated by oxidants in ras-transformed fibroblasts. Science 1997, 275(5306):1649-1652.
40. Bonni A., Brunet A., West A.E., Datta S.R., Takasu M.A., Greenberg M.E. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 1999, 286(5443):1358-1362.
41. Ehlers M.D. Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system. Nat Neurosci 2003, 6(3):231-242.
42. Herskowitz I. MAP kinase pathways in yeast - for mating and more. Cell 1995, 80(2):187-197.
43. Kyriakis J.M., Avruch J. Sounding the alarm: protein kinase cascades activated by stress and inflammation. J Biol Chem 1996, 271(40):24313-24316.
44. Marshall C.J. Specificity of receptor tyrosine kinase signaling - transient versus sustained extracellular signal-regulated kinase activation. Cell 1995, 80(2):179-185.
45. Kyriakis J.M., Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 2001, 81(2):807-869.
46. Rigas B., Goldman I.S., Levine L. Altered eicosanoid levels in human colon cancer. J Lab Clin Med 1993, 122(5):518-523.
47. Dubois R.N., Abramson S.B., Crofford L., Gupta R.A., Simon L.S., Van De Putte L.B.A., et al. Cyclooxygenase in biology and disease. FASEB J 1998, 12(12):1063-1073.
48. Hooper D.C., Bagasra O., Marini J.C., Zborek A., Ohnishi S.T., Kean R., et al. Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: Implications for the treatment of multiple sclerosis. Proc Natl Acad Sci USA 1997, 94(6):2528-2533.
49. Iyengar R., Stuehr D.J., Marletta M.A. Macrophage synthesis of nitrite, nitrate, and N-nitrosamines - precursors and role of the respiratory burst. Proc Natl Acad Sci USA 1987, 84(18):6369-6373.
50. Minghetti L. Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J Neuropathol Exp Neurol 2004, 63(9):901-910.
51. Kroncke K.D., Fehsel K., Kolb-Bachofen V. Inducible nitric oxide synthase in human diseases. Clin Exp Immunol 1998, 113(2):147-156.
52. Good P.F., Werner P., Hsu A., Olanow C.W., Perl D.P. Evidence for neuronal oxidative damage in Alzheimer's disease. Am J Pathol 1996, 149(1):21-28.
53. Liang Y.C., Huang Y.T., Tsai S.H., Lin-Shiau S.Y., Chen C.F., Lin J.K. Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages. Carcinogenesis 1999, 20(10):1945-1952.
54. Herschman H.R. Primary response genes induced by growth-factors and tumor promoters. Annu Rev Biochem 1991, 60:281-319.
55. Williams C.S., Mann M., DuBois R.N. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 1999, 18(55):7908-7916.
56. Jun H.J., Kim Y.M., Park S.Y., Park J.S., Lee E.J., Choi S.A., et al. Modulation of ionizing radiation-induced G2 arrest by cyclooxygenase-2 and its inhibitor celecoxib. Int J Radiat Oncol Biol Phys 2009, 75(1):225-234.
57. Marnett L.J. Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res 1992, 52(20):5575-5589.
58. Hancock C.N., Macias A., Lee E.K., Yu S.Y., MacKerell A.D., Shapiro P. Identification of novel extracellular signal-regulated kinase docking domain inhibitors. J Med Chem 2005, 48(14):4586-4595.
59. Bennett B.L., Sasaki D.T., Murray B.W., O'Leary E.C., Sakata S.T., Xu W.M., et al. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci USA 2001, 98(24):13681-13686.
60. Gallagher T.F., Seibel G.L., Kassis S., Laydon J.T., Blumenthal M.J., Lee J.C., et al. Regulation of stress-induced cytokine production by pyridinylimidazoles; inhibition of CSBP kinase. Bioorg Med Chem 1997, 5(1):49-64.
61. Arumugam T.V., Arnold N., Proctor L.M., Newman M., Reid R.C., Hansford K.A., et al. Comparative protection against rat intestinal reperfusion injury by a new inhibitor of sPLA(2), COX-1 and COX-2 selective inhibitors, and an LTC4 receptor antagonist. Br J Pharmacol 2003, 140(1):71-80.